Show simple item record

dc.contributor.authorDelaney, M. Keegan
dc.contributor.authorLiu, Junling
dc.contributor.authorZheng, Yi
dc.contributor.authorBerndt, Michael C.
dc.contributor.authorDu, Xiaoping
dc.date.accessioned2013-12-03T19:34:00Z
dc.date.available2013-12-03T19:34:00Z
dc.date.issued2012-11
dc.identifier.bibliographicCitationDelaney, M. K., Liu, Junling, Zheng, Yi, Berndt, Michael C., & Du, Xiaoping (2012). The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation. Arteriosclerosis, Thrombosis, and Vascular Biology. 32(11):2761-8. doi: 10.1161/ATVBAHA.112.254920.en_US
dc.identifier.issn1524-4636
dc.identifier.urihttp://hdl.handle.net/10027/10722
dc.descriptionThe original version is available through American Heart Association at DOI: 10.1161/ATVBAHA.112.254920. The final publication is available at http://atvb.ahajournals.org/en_US
dc.description.abstractOBJECTIVE: The platelet receptor for von Willebrand factor, the glycoprotein Ib-IX (GPIb-IX) complex, mediates platelet adhesion at sites of vascular injury and transmits signals leading to platelet activation. von Willebrand factor/GPIb-IX interaction sequentially activates the Src family kinase Lyn (SFK), phosphoinositide 3-kinase (PI3K), and Akt, leading to activation of integrin α(IIb)β(3) and integrin-dependent stable platelet adhesion and aggregation. It remains unclear how Lyn activates the PI3K/Akt pathway after ligand binding to GPIb-IX. METHODS AND RESULTS: Using platelet-specific Rac1(-/-) mice and the Rac1 inhibitor NSC23766, we examined the role of Rac1 in GPIb-IX-dependent platelet activation. Rac1(-/-) mouse platelets and NSC23766-treated human platelets were defective in GPIb-dependent stable adhesion to von Willebrand factor under shear stress, integrin activation, thromboxane A(2) synthesis, and platelet aggregation. Interestingly, GPIb-induced activation of Rac1 and the guanine nucleotide exchange factor for Rac1, Vav, was abolished in both Lyn(-/-) and SFK inhibitor-treated platelets but was unaffected by the PI3K inhibitor LY294002, indicating that Lyn mediates activation of Vav and Rac1 independently of PI3K. Furthermore, GPIb-induced activation of Akt was abolished in Rac1-deficient platelets, suggesting that Rac1 is upstream of the PI3K/Akt pathway. CONCLUSIONS: A Lyn-Vav-Rac1-PI3K-Akt pathway mediates von Willebrand factor-induced activation of integrin α(IIb)β(3) to promote GPIb-IX-dependent platelet activation.en_US
dc.description.sponsorshipThis work is supported, in part, by National Heart, Lung, and Blood Institute/National Institutes of Health grants HL062350, HL068819, and HL080264 (to X.D.). M.K.D. is a recipient of the American Heart Association Midwest Affiliate Predoctoral Fellowship Award No. 11PRE7590050.en_US
dc.language.isoen_USen_US
dc.publisherAmerican Heart Associationen_US
dc.subjectglycoprotein Ib-IXen_US
dc.subjectplateleten_US
dc.subjectplatelet adhesionen_US
dc.titleThe Role of Rac1 in Glycoprotein Ib-IX-Mediated Signal Transduction and Integrin Activationen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record